Crosslinkable macromers bearing initiator groups

• US 6,007,833 A
• Filed: 07/23/1998
• Issued: 12/28/1999
• Est. Priority Date: 03/19/1998
• Status: Expired due to Term

• Current Assignee: Surmodics Incorporated
• Original Assignee: Surmodics Incorporated
• Inventors: Anderson, Aron B., Chudzik, Stephen J.
• Primary Examiner(s): Russel, Jeffrey E.
• Application Number:
  US09/121,248
• Time in Patent Office: 523 Days
• Field of Search: 424/424, 424/425, 424/443, 424/444, 424/445, 424/484, 424/485, 424/486, 424/487, 424/488, 435/177, 435/178, 435/179, 435/180, 435/181, 435/182, 156/275.5, 156/326, 156/327, 156/328, 156/329, 156/330, 156/330.9, 156/331.1, 156/331.2, 156/331.3, 156/331.4, 156/331.5, 156/331.6, 156/331.7 , 156/331.8, 156/331.9, 156/332, 156/333, 156/334, 156/335, 156/336, 156/337, 156/338, 525/50, 525/54.1, 525/54.3, 525/54.31, 522/34, 522/35, 522/87, 522/88, 522/109, 522/110, 522/111, 522/112, 522/904, 522/905
• US Class Current: 424/425
• CPC Class Codes: A61K 2035/128 capsules, e.g. microcapsules
• CPC Class Codes: A61K 38/1875 Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
• CPC Class Codes: A61K 47/32 Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers , poly(meth)acrylates, or polyvinyl pyrrolidone
• CPC Class Codes: A61K 47/34 Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers A61K47/10 takes precedence
• CPC Class Codes: A61K 9/0024 Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L
• CPC Class Codes: A61K 9/1641 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
• CPC Class Codes: A61K 9/1647 Polyesters, e.g. poly(lactide-co-glycolide)
• CPC Class Codes: A61L 24/0031 Hydrogels or hydrocolloids
• CPC Class Codes: A61L 24/0042 Materials resorbable by the body
• CPC Class Codes: A61L 24/046 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L24/043 takes precedence
• CPC Class Codes: A61L 27/34 Macromolecular materials
• CPC Class Codes: A61L 29/085 Macromolecular materials
• CPC Class Codes: A61L 31/148 Materials at least partially resorbable by the body
• CPC Class Codes: C08B 37/0072 Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
• CPC Class Codes: C08F 251/00 Macromolecular compounds obtained by polymerising monomers on to polysaccharides or derivatives thereof
• CPC Class Codes: C08F 251/02 on to cellulose or derivatives thereof
• CPC Class Codes: C08F 290/00 Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
• CPC Class Codes: C08L 2666/02 Organic macromolecular compounds, natural resins, waxes or and bituminous materials
• CPC Class Codes: C08L 33/06 of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
• CPC Class Codes: C08L 51/02 grafted on to polysaccharides
• CPC Class Codes: Y10S 522/904 : Monomer or polymer contains initiating group
• CPC Class Codes: Y10S 522/905 : Benzophenone group

Abstract

A crosslinkable macromer system that includes two or more polymer-pendent polymerizable groups and one or more polymer-pendent initiator groups. The polymerizable groups and the initiator group(s) can be pendent on the same or different polymeric backbones. The macromer system provides advantages over the use of polymerizable macromers and separate, low molecular weight initiators, including advantages with respect to such properties as nontoxicity, efficiency, and solubility.

Claims

1. A crosslinkable macromer system comprising one or more polymers providing pendent polymerizable and pendent initiator groups wherein the system is adapted to be polymerized in order to form a matrix suitable for iin vivo application, and wherein either:

(a) the polymerizable groups and initiator group(s) are pendent on different polymers and the initiator groups are independently selected from the group consisting of long wave ultraviolet activatable molecules selected from the group consisting of benzophenone, thioxanthones, and benzoin ethers;

visible light activatable molecules selected from the group consisting of ethyl eosin, eosin Y, rose bengal, camphorquinone and erythrosin; and

thermally activatable molecules selected from the group consisting of 4,4'"'"' azobis(4-cyanopentanoic) acid, and 2,2-azobis[2-(2-imidazolin-2-yl) propane] dihydrochloride, and benzoyl peroxide; and

the pendent polymerizable groups are selected from the group consisting of vinyl groups, acrylate groups, methacrylate groups, ethacrylate groups, 2-phenyl acrylate groups, acrylamide groups, methacrylamide groups, itaconate groups, and styrene groups, or

(b) the polymerizable groups and the initiator group(s) are pendent on the same polymer and the initiator groups are independently selected from the group consisting of long wave ultraviolet activatable molecules selected from the group consisting of thioxanthones, and benzoin ethers;

visible light activatable molecules selected from the group consisting of ethyl eosin, eosin Y, rose bengal, camphorquinone and erythrosin; and

thermally activatable molecules selected from the group consisting of 4,4'"'"' azobis(4-cyanopentanoic) acid, and 2,2-azobis[2-(2-imidazolin-2-yl) propane] dihydrochloride, and benzoyl peroxide; and

the pendent polymerizable groups are selected from the group consisting of vinyl groups, acrylate groups, methacrylate groups, ethacrylate groups, 2-phenyl acrylate groups, acrylamide groups, methacrylamide groups, itaconate groups, and styrene groups;

or

(c) the polymerizable groups and the initiator group(s) are pendent on the same polymer and the initiator groups are independently selected from the group consisting of long wave ultraviolet activatable molecules selected from the group consisting of benzophenone, thioxanthones, and benzoin ethers;

visible light activatable molecules selected from the group consisting of ethyl eosin, eosin Y, rose bengal, camphorquinone and erythirosin; and

thermally activatable molecules selected from the group consisting of 4,4'"'"' azobis(4-cyanopentanoic) acid, and 2,2-azobis[2-(2-imidazolin-2-yl) propane] dihydrochloride, and benzoyl peroxide; and

the pendent polymerizable groups are selected from the group consisting of acrylate groups, methacrylate groups, ethacrylate groups, 2-phenyl acrylate groups, acrylamide groups, methacrylamide groups, itaconate groups, and styrene groups.

2. A macromer system according to claim 1 wherein the pendent initiator groups are bonded to one or more monomers used to prepare the polymer.

3. A macromer system according to claim 1 wherein the pendent initiator groups are bonded to the polymer itself.

4. A macromer system according to claim 1 wherein the system comprises polymers bearing both initiator groups and polymerizable groups in combination with polymers providing only pendent polymerizable groups.

5. A macromer system according to claim 1 wherein photoinitiation occurs by means of a hydrogen abstraction reaction.

6. A macromer system according to claim 5 wherein the system further comprises one or more polymer-pendent energy transfer acceptor molecules.

7. A macromer system according to claim 6 wherein the energy transfer molecule is selected from the group consisting of tertiary amines.

8. A macromer system according to claim 1 wherein the groups are pendent upon polymers selected from the group consisting of synthetic polymers and naturally-occurring polymers.

9. A macromer system according to claim 8 wherein the polymer is selected from the group consisting of biodegradable polymers and biostable polymers.

10. A macromer system according to claim 9 wherein the polymer is selected from the group consisting of polymers adapted to form hydrogel matricies and polymers adapted to form non-hydrogel matrices.

11. A macromer system according to claim 10 wherein the polymer comprises a biodegradable polymer adapted to form hydrogel matrices.

12. A macromer system according to claim 11 wherein the polymer is a naturally-occurring polymer selected from the group consisting of polysaccharides and polyamino acids.

13. A macromer system according to claim 12 wherein the polysaccharides are selected from the group consisting of hyaluronic acid, starch, dextran, heparin, and chitosan, and the polyamino acids are selected from the group consisting of gelatin, collagen, fibronectin, laminin, albumin and active peptide domains thereof.

14. A macromer system according to claim 8 wherein the polymer comprises a synthetic polymer prepared via condensation polymerization of one or more monomers.

15. A macromer system according to claim 9 wherein the polymers are hydrophobic, biodegradable polymers selected from the group consisting of polylactides, polyglycolides, polycaprolactones, and copolymers of any combination of lactides, glycolides and caprolactones, and further consisting of polyanhydrides and polyortho esters.

16. A macromer system according to claim 9 wherein the polymers are biostable, hydrophilic polymers selected from the group consisting of polyvinylpyrrolidone, polyethylene glycol, polyacrylamide, and polyvinyl alcohol.

17. A macromer system according to claim 9 wherein the polymers are synthetic, biostable polymers formed by the polymerization of hydrophobic monomers selected from the group consisting of methyl methacrylate, butyl methacrylate, and dimethyl siloxanes.

18. A macromer system according to claim 1 wherein the polymers further comprise pendent reactive groups or affinity groups.

19. A macromer system according to claim 18 herein the reactive groups or affinity groups are adapted to bind to target groups on a surface of interest.

20. A method of forming a polymeric matrix adapted for in vivo application, the method comprising the steps of providing a macromer system according to claim 1, applying the system to a substrate, and cross-linking the system by free radical polymerization to form a matrix.

21. A method according to claim 20, wherein the in vivo application is selected from the group consisting of cellular encapsulation, adhesives/sealants, barriers, controlled release carriers, tissue replacement, wound dressing, and in situ device formation.

22. A method according to claim 20 wherein photoinitiation of the system occurs by means of a hydrogen abstraction reaction.

23. A method according to claim 22 wherein the system further comprises one or more polymer-pendent energy transfer acceptor molecules.

24. A method according to claim 23 wherein the energy transfer acceptor molecules are selected from the group consisting of tertiary amines.

25. A method according to claim 22 wherein photoinitiation results in the formation of covalent bonds between the matrix and the substrate.

26. A polymeric matrix adapted for in vivo application the matrix comprising a macromer system according to claim 1, the system having bean applied to a substrate and cross-linked by free radical polymerization to form a matrix.

27. A matrix according to claim 26, wherein the in vivo application is selected from the group consisting of cellular encapsulation, adhesives/sealants, barriers, controlled release carriers, tissue replacement, wound dressing, and in situ device formation.

28. A matrix according to claim 26 wherein photoinitiation of the system occurs by means of a hydrogen abstraction reaction.

29. A matrix according to claim 28 wherein the system further comprises one or more polymer-pendent energy transfer acceptor molecules.

30. A matrix according to claim 29 wherein the energy transfer acceptor molecules are selected from the group consisting of tertiary amines.

31. A matrix according to claim 28 wherein photoinitiation results in the formation of covalent bonds between the matrix and the substrate.

32. A macromer system according to claim 1 wherein the thioxanthones are selected from the group consisting of [(9-oxo-2-thioxanthanyl)-oxy]acetic acid and 2-hydroxy thioxanthone, and the benzoin ethers comprise vinyloxymethylbenzoin methyl ether.

33. A method according to claim 20 wherein the thioxanthones are selected from the group consisting of [(9-oxo-2-thioxanthanyl)-oxy]acetic acid and 2-hydroxy thioxanthone, and the benzoin ethers comprise vinyloxymethylbenzoin methyl ether.

34. A polymeric matrix according to claim 26 wherein the thioxanthones are selected from the group consisting of [(9-oxo-2-thioxanthanyl)-oxy]acetic acid and 2-hydroxy thioxanthone, and the benzoin ethers comprise vinyloxymethylbenzoin methyl ether.

35. A method of forming a polymeric matrix adapted for in vivo application, the method comprising the steps of providing a macromer system according to claim 1, applying the system to a substrate, and cross-linking the system by free radical polymerization to form a matrix, wherein photoinitiation of the system occurs by means of a hydrogen abstraction reaction, and wherein photoinitiation results in the formation of covalent bonds between the matrix and the substrate.

36. A polymeric matrix adapted for in vivo application, the matrix comprising a macromer system according to claim 1, the system having been applied to a substrate and cross-linked by free radical polymerization to form a matrix, wherein photoinitiation of the system occurs by means of a hydrogen abstraction reaction, and wherein photoinitiation results in the formation of covalent bonds between the matrix and the substrate.

37. A polymeric matrix adapted for in vivo application, the matrix comprising a macromer system according to claim 1, the system having been applied to a substrate and cross-linked by free radical polymerization to form a matrix, wherein photoinitiation of the system occurs by means of a hydrogen abstraction reaction, and wherein the thioxanthones are selected from the group consisting of [(9-oxo-2-thioxanthanyl)-oxy]acetic acid and 2-hydroxy thioxanthone, and the benzoin ethers comprise vinyloxymethylbenzoin methyl ether.

38. A crosslinkable macromer system comprising one or more polymers providing pendent polymerizable and pendent initiator groups wherein the system is adapted to be polymerized in order to form a matrix suitable for in vivo application, and wherein the initiator groups are independently selected from the group consisting of long wave ultraviolet activatable molecules selected from the group consisting of benzophenone, thioxanthones, and benzoin ethers;

visible light activatable molecules selected from the group consisting of ethyl eosin, eosin Y, rose bengal, camphorquinone and erythrosin; and

thermally activatable molecules selected from the group consisting of 4,4'"'"' azobis(4-cyanopentanoic) acid, and 2,2-azobis[2-(2-imidazolin-2-yl) propane] dihydrochloride, and benzoyl peroxide; and

the pendent polymerizable groups are selected from the group consisting of vinyl groups, acrylate groups, methacrylate groups, ethacrylate groups, 2-phenyl acrylate groups, acrylamide groups, methacrylamide groups, itaconate groups, and styrene groups, wherein the system comprises polymers bearing both initiator groups and polymerizable groups in combination with polymers providing only pendent polymerizable groups.

39. A crosslinkable macromer system comprising one or more polymers providing pendent polymerizable and pendent initiator groups wherein the system is adapted to be polymerized in order to form a matrix suitable for in vivo application, and wherein the initiator groups are independently selected from the group consisting of long wave ultraviolet activatable molecules selected from the group consisting of benzophenone, thioxanthones, and benzoin ethers;

visible light activatable molecules selected from the group consisting of ethyl eosin, eosin Y, rose bengal, camphorquinone and erythrosin; and

thermally activatable molecules selected from the group consisting of 4,4'"'"' azobis(4-cyanopentanoic) acid, and 2,2-azobis[2-(2-imidazolin-2-yl) propane] dihydrochloride, and benzoyl peroxide; and

the pendent polymerizable groups are selected from the group consisting of vinyl groups, acrylate groups, methacrylate groups, ethacrylate groups, 2-phenyl acrylate groups, acrylamide groups, methacrylamide groups, itaconate groups, and styrene groups, wherein the groups are pendent upon biodegradable polymers adapted to form hydrogel matrices.

40. A macromer system according to claim 39 wherein the polymer is a naturally-occurring polymer selected from the group consisting of polysaccharides and polyamino acids.

41. A macromer system according to claim 40 wherein the polysaccharides are selected from the group consisting of hyaluronic acid, starch, dextran, heparin, and chitosan, and the polyamino acids are selected from the group consisting of gelatin, collagen, fibronectin, laminin, albumin and active peptide domains thereof.

42. A crosslinkable macromer system comprising one or more polymers providing pendent polymerizable and pendent initiator groups wherein the system is adapted to be polymerized in order to form a matrix suitable for in vivo application, and wherein the initiator groups are independently selected from the group consisting of long wave ultraviolet activatable molecules selected from the group consisting of benzophenone, thioxanthones, and benzoin ethers;

visible light activatable molecules selected from the group consisting of ethyl eosin, eosin Y, rose bengal, camphorquinone and erythrosin; and

thermally activatable molecules selected from the group consisting of 4,4'"'"' azobis(4-cyanopentanoic) acid, and 2,2-azobis[2-(2-imidazolin-2-yl) propane] dihydrochloride, and benzoyl peroxide; and

the pendent polymerizable groups are selected from the group consisting of vinyl groups, acrylate groups, methacrylate groups, ethacrylate groups, 2-phenyl acrylate groups, acrylamide groups, methacrylamide groups, itaconate groups, and styrene groups, wherein the polymer comprises a synthetic polymer prepared via condensation polymerization of one or more monomers.

43. A macromer system according to claim 42 wherein the polymers are hydrophobic, biodegradable polymers selected from the group consisting of polylactides, polyglycolides, polycaprolactones, and copolymers of any combination of lactides, glycolides and caprolactones, and further consisting of polyanhydrides and polyortho esters.

44. A crosslinkable macromer system comprising one or more polymers providing pendent polymerizable and pendent initiator groups wherein the system is adapted to be polymerized in order to form a matrix suitable for in vivo application, and wherein the initiator groups are independently selected from the group consisting of long wave ultraviolet activatable molecules selected from the group consisting of benzophenone, thioxanthones, and benzoin ethers;

visible light activatable molecules selected from the group consisting of ethyl eosin, eosin Y, rose bengal, camphorquinone and erythrosin; and

thermally activatable molecules selected from the group consisting of 4,4'"'"' azobis(4-cyanopentanoic) acid, and 2,2-azobis[2-(2-imidazolin-2-yl) propane] dihydrochloride, and benzoyl peroxide; and

the pendent polymerizable groups are selected from the group consisting of vinyl groups, acrylate groups, methacrylate groups, ethacrylate groups, 2-phenyl acrylate groups, acrylamide groups, methacrylamide groups, itaconate groups, and styrene groups, wherein the polymers further comprise pendent reactive groups or affinity groups, and wherein the reactive groups or affinity groups are adapted to bind to target groups on a surface of interest.